Infant Colonization With Methicillin-Resistant Staphylococcus aureus or Vancomycin-Resistant Enterococci Preceding Neonatal Intensive Care Unit Discharge.
Sarah A Clock, Haomiao Jia, Sameer Patel, Yu-Hui Ferng, Luis Alba, Susan Whittier, Patricia DeLaMora, Setareh Tabibi, Jeffrey Perlman, David Paul, Theoklis Zaoutis, Elaine Larson, Lisa Saiman
Author Information
Sarah A Clock: Departments of Pediatrics.
Haomiao Jia: Columbia University School of Nursing, New York.
Sameer Patel: Departments of Pediatrics.
Yu-Hui Ferng: Columbia University School of Nursing, New York.
Luis Alba: Departments of Pediatrics.
Susan Whittier: Pathology, Columbia University Medical Center, New York.
Patricia DeLaMora: Department of Pediatrics, Weill Cornell Medical College, New York.
Setareh Tabibi: Departments of Pediatrics.
Jeffrey Perlman: Department of Pediatrics, Weill Cornell Medical College, New York.
David Paul: Christiana Neonatal Associates, Christiana Care Health System, Newark, Delaware.
Theoklis Zaoutis: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Elaine Larson: Columbia University School of Nursing, New York.
Rates of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and/or vancomycin-resistant enterococci (VRE) were determined for 1320 infants within 7 days of neonatal intensive care unit discharge. Overall, 4% and 1% of the infants were colonized with MRSA or VRE, respectively. Predictors identified in fixed-effects models were surgery during hospitalization (for MRSA colonization) and prolonged antimicrobial treatment (for VRE colonization).
